SCHEMBL1892579

SCHEMBL1892579

CC(C)CC1CCC(CCC=O)CC1

nearest known ligand 0.31

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
ANPEP P15144 1/20 0.31
ENPEP Q07075 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31412817 1.00 ANPEP (0.31) ANPEPENPEP
SCHEMBL17629899 1.00 ANPEP (0.31) ANPEPENPEP
SCHEMBL98083 0.82
SCHEMBL1897478 0.80 ALDH1A1 (0.32)
SCHEMBL1901885 0.79
SCHEMBL1669308 0.78
Formic Acid SCHEMBL29446927 0.78 ANPEP (0.34) ANPEPENPEP
Methane SCHEMBL2401725 0.78
SCHEMBL24117512 0.77
SCHEMBL24117507 0.77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 125 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4114914-B1 FRAGRANCE PREMIX COMPOSITIONS AND RELATED CONSUMER PRODUCTS PROCTER & GAMBLE (US) 2025-06-25 EP claimed
CN-115210352-B Perfume premix compositions and related consumer products 宝洁公司 2025-03-18 CN claimed
US-11618864-B2 Fragrance premix composition comprising a silicone polymer and aminofunctional material THE PROCTER & GAMBLE COMPANY (US) 2023-04-04 US claimed
US-20230037431-A1 FRAGRANCE PREMIX COMPOSITIONS AND RELATED CONSUMER PRODUCTS PROCTER & GAMBLE (US) 2023-02-09 US claimed
EP-4114914-A1 FRAGRANCE PREMIX COMPOSITIONS AND RELATED CONSUMER PRODUCTS The Procter & Gamble Company (US) 2023-01-11 EP claimed
CN-115210352-A Perfume premix compositions and related consumer products 宝洁公司 2022-10-18 CN claimed
WO-2021179010-A1 FRAGRANCE PREMIX COMPOSITIONS AND RELATED CONSUMER PRODUCTS THE PROCTER & GAMBLE COMPANY (US) 2021-09-10 WO claimed
US-20210277327-A1 FRAGRANCE PREMIX COMPOSITIONS AND RELATED CONSUMER PRODUCTS THE PROCTER & GAMBLE COMPANY 2021-09-09 US claimed
EP-3124478-B1 NOVEL ORGANOLEPTIC COMPOUNDS INT FLAVORS & FRAGRANCES INC (US) 2018-10-31 EP claimed
US-9816048-B2 Organoleptic compounds INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) 2017-11-14 US claimed
EP-3192566-A1 POLYALKOXY-POLYIMINE ADDUCTS FOR USE IN DELAYED RELEASE OF FRAGRANCE INGREDIENTS International Flavors & Fragrances Inc. (US) 2017-07-19 EP claimed
US-20170029741-A1 NOVEL ORGANOLEPTIC COMPOUNDS INTERNATIONAL FLAVORS AND FRAGRANCES INC. 2017-02-02 US claimed
EP-3124478-A1 NOVEL ORGANOLEPTIC COMPOUNDS International Flavors & Fragrances Inc. (US) 2017-02-01 EP claimed
EP-2322495-B1 Novel 4-alkyl cyclohexanepropanal compounds and their use in perfume compositions INT FLAVORS & FRAGRANCES INC (US) 2013-01-02 EP claimed
EP-2333038-B1 Novel 4-Alkyl Cyclohexanepropanal Compounds and their use in Perfume Compositions INT FLAVORS & FRAGRANCES INC (US) 2012-06-13 EP claimed
US-8188023-B2 4-alkyl cyclohexanepropanal compounds and their use in perfume compositions INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) 2012-05-29 US claimed
EP-2333038-A1 Novel 4-Alkyl Cyclohexanepropanal Compounds and their use in Perfume Compositions INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) 2011-06-15 EP claimed
US-20110117046-A1 NOVEL 4-ALKYL CYCLOHEXANEPROPANAL COMPOUNDS AND THEIR USE IN PERFUME COMPOSITIONS INTERNATIONAL FLAVORS & FRAGRANCES INC. 2011-05-19 US claimed
EP-2322495-A1 Novel 4-alkyl cyclohexanepropanal compounds and their use in perfume compositions International Flavors & Fragrances Inc. (US) 2011-05-18 EP claimed
US-7834219-B1 4-alkyl cyclohexanepropanal compounds and their use in perfume compositions INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) 2010-11-16 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110117046-A1 NOVEL 4-ALKYL CYCLOHEXANEPROPANAL COMPOUNDS AND THEIR USE IN PERFUME COMPOSITIONS TRPA1, FAAH2, FAAH ANPEP 3049/4885ENPEP 2967/4885
US-20170029741-A1 NOVEL ORGANOLEPTIC COMPOUNDS TRPA1, TRPV1, TRPV5 ANPEP 3526/4885ENPEP 2754/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.